Package 68001-573-41

{"route": ["INTRAVENOUS"], "spl_id": "fc96fe77-06cc-dc04-e053-6394a90a99da", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["776B62CQ27"], "rxcui": ["636631"], "spl_set_id": ["6c6ab831-6234-4803-8a01-5c51ec3b0716"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL in 1 CARTON (68001-573-41)  / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL", "package_ndc": "68001-573-41", "marketing_start_date": "20230523"}], "brand_name": "DECITABINE", "product_id": "68001-573_fc96fe77-06cc-dc04-e053-6394a90a99da", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "68001-573", "generic_name": "decitabine", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "DECITABINE", "active_ingredients": [{"name": "DECITABINE", "strength": "50 mg/1"}], "application_number": "ANDA210984", "marketing_category": "ANDA", "marketing_start_date": "20230523", "listing_expiration_date": "20261231"}